back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-28 10:41 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+43,333 vol |
160,333 | |
| Filed 2024-03-28 10:40 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+117,000 vol |
117,000 | |
| Filed 2024-03-28 10:40 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-28 10:40 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-23,333 vol |
133,334 | |
| Filed 2024-03-28 10:39 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-63,000 vol |
156,667 | |
| Filed 2024-03-28 10:39 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-43,333 vol |
219,667 | |
| Filed 2024-03-28 10:38 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-117,000 vol |
263,000 | |
| Filed 2024-03-18 11:47 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+180,000 vol |
380,000 | |
| Filed 2024-03-18 11:46 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+200,000 vol |
200,000 | |
| Filed 2024-03-18 11:45 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-15 15:03 Tx date 2023-08-11 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
525,000 | |
| Filed 2019-10-24 06:27 Tx date 2019-09-25 |
$
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Units Common Shares/Half Warrant
00 - Opening Balance-Initial SEDI Report
|
166,000 | ||
| Filed 2019-10-23 04:54 Tx date 2019-09-25 |
$
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-23 04:55 Tx date 2019-09-25 |
$
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2019-10-23 04:54 Tx date 2019-09-25 |
$
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
166,667 |